Study contends lifestyle, chronic ailments to drive 56% growth in value of global peritoneal dialysis market through 2027 -

A report (available for purchase) from Canadian research firm Emergen Research suggests the global peritoneal dialysis (PD) market will grow at an annual rate of 5.6%, so that by 2027, it will be worth $5.73 billion. In 2019, the worldwide PD market was estimated to be worth $3.68 billion. Emergen says the growth will be driven by human factors such as higher incidences of kidney diseases, lifestyle diseases and chronic diseases that affect kidney function. Also contributing to industry growth will be investments in healthcare delivery, diagnostics and medical equipment advances, such that innovative firms in the peritoneal dialysis space should be favored. The report anticipates the global market landscape will remain fragmented between small start-ups, medium enterprises and large conglomerates. In the U.S., key players will include Baxter International, Covidien, DaVita, Dialysis Clinic, Inc., Diversified Specialty Institute Holdings, Fresenius Medical Care, Medical Components, Inc., Northwest Kidney Centers, NxStage Medical, Satellite Healthcare and U.S. Renal Care.